Back to search

Safety and efficacy of panitumumab (pmab) in HPV-positive (+) and HPV-negative (-) recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Analysis of the global phase III SPECTRUM trial.

Jan Stoehlmacher-Williams, Cristian Villanueva, Paolo Foa, Sylvie Rottey, Eric Winquist
DOI: 10.1200/jco.2012.30.15_suppl.5504
Journal of Clinical Oncology

Data up to Jan 2025

Published2012
Citations24
References0
Fields
MedicineInternal medicineOncologySurgery

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Safety and efficacy of panitumumab (pmab) in HPV-positive (+) and HPV-negative (-)… (2012) – Journal of Clinical Oncology | Metascience Observatory Explorer